We are live on ! Find out more
CALT

Calliditas Therapeutics AB American Depositary Shares
CALT

Delisted

CALT was delisted on the 20th of September, 2024.

Back to rankings

11 hedge funds and large institutions have $96.9M invested in Calliditas Therapeutics AB American Depositary Shares in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more capital invested

Capital invested by funds: $67.2M → $96.9M (+$29.7M)

31% less funds holding

Funds holding: 16 → 11 (-5)

71% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 7

86% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 7

Holders
11
Holders Change
-5
Holders Change %
-31.25%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
7
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HA
HHLR Advisors
Cayman Islands
+$21.2M

Top Sellers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
-$8.19M
2
LGM
Logos Global Management
California
-$7.61M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.72M
4
ECM
Endurant Capital Management
California
-$2.67M
5
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$586K
Name Holding Trade Value Shares
Change 		Change in
Stake
HA
1
HHLR Advisors
Cayman Islands
$35.6M +$21.2M +697,687 +199%
BI
2
BVF Inc
California
$25.5M – – –
VC
3
Vivo Capital
California
$10.5M -$8.19M -268,970 -46%
LGM
4
Logos Global Management
California
$10.1M -$7.61M -250,000 -45%
OCA
5
Octagon Capital Advisors
New York
$6.72M +$6.09M +200,000 New
Point72 Asset Management
6
Point72 Asset Management
Connecticut
$3.45M -$4.72M -155,144 -60%
Deutsche Bank
7
Deutsche Bank
Germany
$2.36M -$122K -4,000 -5%
PCM
8
Pentwater Capital Management
Florida
$1.68M -$337K -11,084 -18%
Millennium Management
9
Millennium Management
New York
$696K -$540K -17,737 -46%
Jane Street
10
Jane Street
New York
$256K -$82.8K -2,721 -26%
LSA
11
Leonteq Securities AG
Switzerland
$34K +$30.4K +1,000 New
ECM
12
Endurant Capital Management
California
– -$2.67M -111,467 Closed
Tudor Investment Corp
13
Tudor Investment Corp
Connecticut
– -$586K -24,422 Closed
O
14
OrbiMed
New York
– -$425K -17,696 Closed
BCM
15
Burrage Capital Management
Massachusetts
– -$265K -11,034 Closed
BlackRock
16
BlackRock
New York
– -$29K -1,191 Closed
UBS Group
17
UBS Group
Switzerland
– -$20K -836 Closed
FCA
18
FinTrust Capital Advisors
South Carolina
– -$11 -450 Closed

CALT Hedge Fund Activity: Q4 2020 in Review

11 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Calliditas Therapeutics AB American Depositary Shares (CALT) for Q4 2020, worth a combined $96.9M — up 44% from $67.2M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of CALT and 2 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 1 added.

The largest buyer was HHLR Advisors, adding an estimated $21.2M. The largest seller was Vivo Capital, cutting an estimated $8.19M.

  • 11 institutional investors held Calliditas Therapeutics AB American Depositary Shares (CALT) as of Q4 2020, down from 16 in Q3 2020.
  • Funds reported $96.9M of Calliditas Therapeutics AB American Depositary Shares stock for Q4 2020, up 44% quarter-over-quarter.
  • 2 funds opened new Calliditas Therapeutics AB American Depositary Shares positions in Q4 2020 and 7 closed out, a net change of -5 holders.
  • The largest Calliditas Therapeutics AB American Depositary Shares buyer in Q4 2020 was HHLR Advisors, an estimated $21.2M added.
  • The largest Calliditas Therapeutics AB American Depositary Shares seller in Q4 2020 was Vivo Capital, an estimated $8.19M sold.

Based on aggregated 13F filings for Q4 2020.